Chronic HMG-CoA Reductase Inhibitor Treatment Contributes to Dysglycemia by Up-Regulating Hepatic Gluconeogenesis through Autophagy Induction

被引：0

作者：

Wang, Hye Jin

Park, Jae Yeo

Choe, Eun Yeong

Kwon, Obin

Lee, Yong-Ho

Kim, Gyuri

Bae, Jaehyun

Park, Se Hee

Yun, Yu Jung

Yun, Mijin

Kim, Chul Hoon

Lee, Hyangkyu

Kim, Young Bum

Kang, Eun Seok

机构：

来源：

DIABETES | 2014年 / 63卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1787-P

引用

页码：A461 / A461

页数：1

共 50 条

[21] HEPATIC AND NONHEPATIC STEROL SYNTHESIS AND TISSUE DISTRIBUTION FOLLOWING ADMINISTRATION OF A LIVER SELECTIVE HMG-COA REDUCTASE INHIBITOR, CI-981 - COMPARISON WITH SELECTED HMG-COA REDUCTASE INHIBITORS [J].

BOCAN, TMA ;

FERGUSON, E ;

MCNALLY, W ;

UHLENDORF, PD ;

MUELLER, SB ;

DEHART, P ;

SLISKOVIC, DR ;

ROTH, BD ;

KRAUSE, BR ;

NEWTON, RS .

BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1123 (02) :133-144

[22] Hemodynamic changes associated with reduction in total cholesterol by treatment with the HMG-CoA reductase inhibitor pravastatin [J].

Muramatsu, J ;

Kobayashi, A ;

Hasegawa, N ;

Yokouchi, S .

ATHEROSCLEROSIS, 1997, 130 (1-2) :179-182

[23] EFFECTS OF ONE-YEAR OF TREATMENT WITH PRAVASTATIN, AN HMG-COA REDUCTASE INHIBITOR, ON LIPOPROTEIN-A [J].

HUNNINGHAKE, DB ;

STEIN, EA ;

MELLIES, MJ .

JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 33 (06) :574-580

[24] HMG-CoA Reductase Inhibitor Statins Activate the Transcriptional Activity of p53 by Regulating the Expression of TAZ [J].

Miyajima, Chiharu ;

Hayakawa, Yurika ;

Inoue, Yasumichi ;

Nagasaka, Mai ;

Hayashi, Hidetoshi .

PHARMACEUTICALS, 2022, 15 (08)

[25] THE EFFECT OF THE HMG-COA REDUCTASE INHIBITOR SIMVASTATIN AND OF CHOLESTYRAMINE ON HEPATIC APOLIPOPROTEIN MESSENGER-RNA LEVELS IN THE RAT [J].

MITCHELL, A ;

FIDGE, N ;

GRIFFITHS, P .

BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1167 (01) :9-14

[26] PRAVASTATIN, HMG-COA REDUCTASE INHIBITOR, STIMULATES INSULIN SECRETION THROUGH ORGANIC ANION TRANSPORTER IN THE PANCREAS [J].

Toyohara, Takafumi ;

Suzuki, Takehiro ;

Abe, Michiaki ;

Shiwaku, Hiromi ;

Akiyama, Yasutoshi ;

Shibata, Eisuke ;

Tanemoto, Masayuki ;

Ohtsuki, Sumio ;

Terasaki, Tetsuya ;

Ito, Sadayoshi ;

Abe, Takaaki .

DRUG METABOLISM REVIEWS, 2007, 39 :279-279

[27] The HMG-CoA Reductase Inhibitor Pravastatin Stimulates Insulin Secretion through Organic Anion Transporter Polypeptides [J].

Abe, Michiaki ;

Toyohara, Takafumi ;

Ishii, Akiko ;

Suzuki, Takehiro ;

Noguchi, Naoya ;

Akiyama, Yasutoshi ;

Shiwaku, Hiromi O. ;

Nakagomi-Hagihara, Rie ;

Zheng, Guodong ;

Shibata, Eisuke ;

Souma, Tomokazu ;

Shindo, Tomohiko ;

Shima, Hirohito ;

Takeuchi, Yoichi ;

Mishima, Eikan ;

Tanemoto, Masayuki ;

Terasaki, Tetsuya ;

Onogawa, Tohru ;

Unno, Michiaki ;

Ito, Sadayoshi ;

Takasawa, Shin ;

Abe, Takaaki .

DRUG METABOLISM AND PHARMACOKINETICS, 2010, 25 (03) :274-282

[28] INSULIN AND GLUCAGON REGULATE HEPATIC HMG-COA REDUCTASE GENE-EXPRESSION BY ENZYME-INDUCTION AND REPRESSION [J].

NESS, GC ;

WIGGINS, L ;

LOPEZ, D ;

ZHAO, ZH .

FASEB JOURNAL, 1994, 8 (07) :A1327-A1327

[29] INDUCTION OF HEPATIC LDL RECEPTORS IN NORMAL AND HETEROZYGOUS WHHL RABBITS TREATED WITH CS-514, AN INHIBITOR OF HMG-COA REDUCTASE, IN COMBINATION WITH CHOLESTYRAMINE [J].

KUME, N ;

MIKAMI, A ;

ISHII, K ;

NAGANO, Y ;

YOKODE, M ;

KITA, T .

ARTERIOSCLEROSIS, 1987, 7 (05) :A548-A549

[30] HMG-CoA reductase inhibitor attenuates experimental autoimmune myocarditis through inhibition of T cell activation [J].

Azuma, RW ;

Suzuki, J ;

Ogawa, M ;

Futamatsu, H ;

Koga, N ;

Onai, Y ;

Kosuge, H ;

Isobe, M .

CARDIOVASCULAR RESEARCH, 2004, 64 (03) :412-420

← 1 2 3 4 5 →